Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of GD-11 for acute ischemic stroke
ChiCTR2400080972Phase 3Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ischemic stroke comparing GD-11 for injection test group with Placebo control group (2 arms). Primary endpoint: Proportion of subjects with mRS score <=1 at day 90. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
GD-11
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2400080972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080972.